Genvax Technologies News Today

Years before messenger ribonucleic acid – mRNA – vaccines were developed to fight COVID-19, rapidly adaptable RNA-based vaccine technologies were being used to fight swine diseases. Harrisvaccines, an animal-health company,

At least five states have introduced bills restricting the use of controversial mRNA technology or gene therapies in ...

Years before the rapid production of mRNA vaccines for COVID-19 was in the news, the vaccine technology was already familiar to Joel Harris and his father, Han

Genvax's goal is to develop a vaccine that matches 100% to the specific strain when an FAD outbreak, such as African swine fever, occurs.

Genvax's goal is to develop a vaccine that matches 100% to the specific strain when an FAD outbreak, such as African swine fever, occurs.